Newsroom | Earlham Institute

Nanosurgical tool could be key to cancer breakthrough

A groundbreaking nanosurgical tool - about 500 times thinner than a human hair - could be transformative for cancer research and give insights into treatment resistance that no other technology has been able to do, according to a new study.

03 November 2021

Prostate cancer urine test identifies good prognosis for patients

A new pilot study published today reveals how urine biomarkers can show the amount of significant cancer in a prostate, highlighting with more certainty which men need treatment.

21 February 2019

Long non-codes in nematodes

Researchers at the Earlham Institute and the Gurdon Institute have identified many functional long non-coding RNAs in the nematode <i>C. elegans</i>.

Our research
- Research strategy
  - Our Culture
  - Open and FAIR Data
- Explore our research
  - Research projects
  - Publications
- Our research programmes
- National Bioscience Research Infrastructures
  - Earlham Biofoundry
  - Transformative Genomics
- Scientific Groups
Technology platforms
Training and events
Stories and impact
About
People
- Staff
Careers
Contact